Umut Sarpel
Overview
Explore the profile of Umut Sarpel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
999
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Khajoueinejad N, Sarfaty E, Yu A, Buseck A, Troob S, Imtiaz S, et al.
Ann Surg Oncol
. 2023 Dec;
31(4):2668-2678.
PMID: 38127214
Background: Frailty, a multidimensional state leading to reduced physiologic reserve, is associated with worse postoperative outcomes. Despite the availability of various frailty tools, surgeons often make subjective assessments of patients'...
12.
Sarfaty E, Khajoueinejad N, Yu A, Hiotis S, Golas B, Sarpel U, et al.
Ann Surg Oncol
. 2023 Nov;
31(3):1970-1979.
PMID: 37989953
Background: Cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) improves survival compared with chemotherapy alone in patients with peritoneal carcinomatosis (PC) of colorectal (CRC) origin, however, long-term survival data are lacking....
13.
Berger Y, Buseck A, Imtiaz S, Horn C, Khajoueinejad N, Macfie R, et al.
Surg Open Sci
. 2023 Sep;
16:28-32.
PMID: 37744313
Introduction: Participant characteristics are known to affect group discourse and discussion outcomes. In medicine, many decisions are made by group consensus, therefore an understanding of these factors is highly relevant....
14.
Berger Y, Sullivan B, Bekhor E, Carpiniello M, Leigh N, Pletcher E, et al.
J Surg Oncol
. 2023 Jul;
128(7):1133-1140.
PMID: 37519102
Background And Objectives: There are no guidelines for intravenous fluid (IVF) administration after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). This study assessed rates of post-CRS/HIPEC morbidity according to perioperative...
15.
Macfie R, Berger Y, Liu H, Li T, Imtiaz S, Ang C, et al.
Ann Surg Oncol
. 2023 May;
30(8):5027-5034.
PMID: 37210446
Introduction: Guidelines for perioperative systemic therapy administration in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma (PDAC) and distal cholangiocarcinoma (dCCA) are evolving. Decisions regarding adjuvant therapy are influenced by postoperative morbidity,...
16.
DAngelica M, Ellis R, Liu J, Brajcich B, Gonen M, Thompson V, et al.
JAMA
. 2023 Apr;
329(18):1579-1588.
PMID: 37078771
Importance: Despite improvements in perioperative mortality, the incidence of postoperative surgical site infection (SSI) remains high after pancreatoduodenectomy. The effect of broad-spectrum antimicrobial surgical prophylaxis in reducing SSI is poorly...
17.
Cha D, Yu A, Khajoueinejad N, Gleeson E, Shaltiel T, Berger Y, et al.
World J Surg
. 2023 Apr;
47(7):1801-1808.
PMID: 37014430
Background: Neoadjuvant therapy (NAT) is increasingly utilized in the treatment of pancreatic ductal adenocarcinoma (PDAC). However, there are limited data on risk factors and patterns of recurrence after surgical resection....
18.
Imtiaz S, Berger Y, Gleeson E, Williams H, Durham D, Mahajan D, et al.
J Surg Res
. 2023 Mar;
287:90-94.
PMID: 36870306
Introduction: Early stage gastric cancer, particularly T1 disease, is associated with high recurrence-free and overall survival rates following resection with curative intent. However, rare cases of T1 gastric cancer have...
19.
Hanna D, Macfie R, Ghani M, Hermina A, Mina A, Cha D, et al.
J Surg Res
. 2022 Dec;
284:94-100.
PMID: 36563453
Introduction: Many patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for appendiceal adenocarcinoma peritoneal metastases (APM) undergo preoperative systemic chemotherapy. The primary aim of this study is to evaluate...
20.
Wang X, He Q, Zhou C, Xu Y, Liu D, Fujiwara N, et al.
Immunity
. 2022 Dec;
56(1):58-77.e11.
PMID: 36521495
Obesity-induced chronic liver inflammation is a hallmark of nonalcoholic steatohepatitis (NASH)-an aggressive form of nonalcoholic fatty liver disease. However, it remains unclear how such a low-grade, yet persistent, inflammation is...